MatthewRubenstein (Matt)

Associate

Minneapolis + 1.612.217.8846

Matt Rubenstein's practice focuses on appellate advocacy and complex litigation. His work has spanned a range of substantive areas including securities regulation, criminal law, and bankruptcy. He has worked on briefs submitted to the U.S Supreme Court; federal bankruptcy, district, and circuit courts; the SEC; and state intermediate and high courts.

Experience

  • Sloan Kettering and Juno Therapeutics win over $1.1 billion after jury verdict and post-trial motions in patent dispute with Kite Pharma/Gilead involving CAR-T therapyOn behalf of patentee Sloan Kettering Institute and exclusive licensee Juno Therapeutics (a subsidiary of Celgene Corporation, a Bristol Myers Squibb company), Jones Day and co-counsel prevailed in a jury trial that spanned eight days and involved 22 witnesses, wherein the jury awarded our clients $752 million in compensation for the infringement of their patents by Kite Pharma, Inc. (a Gilead Sciences, Inc. company) through the making and selling of its infringing CAR-T therapy, YESCARTA®.
  • Legal scholars file amicus brief in Second Circuit in support of sexual assault victim at military academyJones Day filed an amicus brief on behalf of a group of legal scholars to assist the Second Circuit as it considered whether a cadet at the United States Military Academy at West Point could bring claims under the Federal Torts Claims Act for the rape and sexual harassment she endured.